Evaluación de la posible implantación de las vacunas contra el Meningococo B y Rotavirus en España
- Carmen García Huerta 1
- Elena Hernando Garrido 1
- Beatriz Jiménez Roales 1
- Ana Belén Oñoro Morales 1
- Ana Isabel Vidal Conde 1
- María Isabel Gegúndez Cámara dir. 1
-
1
Universidad de Alcalá
info
- Cuadros González, Juan (dir.)
- Gegúndez Cámara, María Isabel (dir.)
- Florido Calleja, María Jesús (ed. lit.)
- Consuelo Giménez Pardo (dir.)
- María Rosario González Palacios (dir.)
- Lourdes Lledó García (dir.)
- Juan Romanyk (dir.)
- José Vicente Saz Pérez (dir.)
Argitaletxea: Editorial Universidad de Alcalá ; Universidad de Alcalá
ISBN: 9788416599493
Argitalpen urtea: 2017
Orrialdeak: 159-172
Mota: Liburuko kapitulua
Laburpena
Meningococcal B vaccine and Rotavirus vaccine have been recently introduced in our country. This study shows the risk and benefits of both vaccines as well as the introduction´s cost in the spanish vaccination programme and the economical savings in the treatment of the diseases that are caused by the microorganisms. The principal objective is give a recommendation about including the vaccines in the National Security System. In both cases we have analized the risks and the benefits of the vaccines by using differents articles and studies published in the last few years. The economical information is from countries that have introduced the vaccines and have a similar situation to our country, in both cases we have concluded that the benefits of having that vaccines financed by the NSS will be greater than the posible risks and presumed costs.